Unlocking the Therapeutic Promise of Human Embryonic Stem Cells
Time: 2:30 pm
day: Day One Track A Afternoon
Details:
- Evaluating the advantages of hESCs over iPSCs in terms of genetic stability, differentiation efficiency, and scalability
- Discussing trials using hESCs, easy derivation, low cost of hESC lines and patient-specific hESCs and SCNT
